Lead exposure, polymorphisms in genes related to oxidative stress, and risk of adult brain tumors

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 6, 2009, Pages 1841-1848

  Bhatti, Parveen ^a,b   Stewart, Patricia A ^c   Hutchinson, Amy ^d   Rothman, Nathaniel ^a   Linet, Martha S ^a   Inskip, Peter D ^a   Rajaraman, Preetha ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Stewart Exposure Assessments LLC   (United States)

^d SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE 1; LEAD;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE PEROXIDASE; HUMANS; LEAD; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RAC GTP-BINDING PROTEINS; RISK FACTORS; YOUNG ADULT;

EID: 67449106486     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0197     Document Type: Article

References (28)

1. IARC. Inorganic and organic lead compounds. Lyon: IARC;2004.
2. Ahamed M, Siddiqui MK. Low level lead exposure and oxidative stress: current opinions. Clin Chim Acta 2007;383:57-64. (Pubitemid 47016452)
3. Silbergeld EK. Facilitative mechanisms of lead as a carcinogen. Mutat Res 2003;533:121-133 (Pubitemid 37487864)
4. Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem 2006;97:1634-1658
5. Cocco P, Dosemeci M, Heineman EF. Brain cancer and occupational exposure to lead. J Occup Environ Med 1998;40:937-942 (Pubitemid 28533719)
6. Cocco P, Heineman EF, Dosemeci M. Occupational risk factors for cancer of the central nervous system (CNS) among US women. Am J Ind Med 1999;36:70-74 (Pubitemid 29283628)
7. Hu J, Little J, Xu T, et al. Risk factors for meningioma in adults: a case-control study in northeast China. Int J Cancer 1999;83:299-304. (Pubitemid 29455750)
8. Hu YJ, Diamond AM. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 2003;63:3347-3351 (Pubitemid 36735893)
9. Navas-Acien A, Pollan M, Gustavsson P, Plato N. Occupation, exposure to chemicals and risk of gliomas and meningiomas in Sweden. Am J Ind Med 2002;42:214-227 (Pubitemid 34907365)
10. van Wijngaarden E, Dosemeci M. Brain cancer mortality and potential occupational exposure to lead: findings from the National Longitudinal Mortality Study, 1979-1989. Int J Cancer 2006;119:1136-1144 (Pubitemid 44116923)
11. Wesseling C, Pukkala E, Neuvonen K, Kauppinen T, Boffetta P, Partanen T. Cancer of the brain and nervous system and occupational exposures in Finnish women. J Occup Environ Med 2002;44:663-668 (Pubitemid 34764981)
12. Wong O, Harris F. Cancer mortality study of employees at lead battery plants and lead smelters, 1947-1995. Am J Ind Med 2000;38:255-270
13. Anttila A, Heikkila P, Nykyri E, et al. Risk of nervous system cancer among workers exposed to lead. J Occup Environ Med 1996;38:131-136 (Pubitemid 26074067)
14. Gerhardsson L, Hagmar L, Rylander L, Skerfving S. Mortality and cancer incidence among secondary lead smelter workers. Occup Environ Med 1995;52:667-672
15. Inskip PD, Tarone RE, Hatch EE, et al. Cellular-telephone use and brain tumors. N Engl J Med 2001;344:79-86. (Pubitemid 32052496)
16. Rajaraman P, Stewart PA, Samet JM, et al. Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev 2006;15:2514-2520 (Pubitemid 46048314)
17. Rajaraman P, Hutchinson A, Rothman N, et al. Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro-oncol 2008;10:709-715
18. Stewart PA, Stewart WF, Heineman EF, Dosemeci M, Linet M, Inskip PD. A novel approach to data collection in a case-control study of cancer and occupational exposures. Int J Epidemiol 1996;25:744-752 (Pubitemid 26290056)
19. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995;57:289-300.
20. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265 (Pubitemid 40202029)
21. Hu J, Johnson KC, Mao Y, et al. Risk factors for glioma in adults: a case-control study in northeast China. Cancer Detect Prev 1998;22:100-108 (Pubitemid 28159331)
22. Idbaih A, Paris S, Boisselier B, et al. Mutational analysis of Rac2 in gliomas. J Neurooncol 2008;87:365-366
23. Hwang SL, Lieu AS, Chang JH, et al. Rac2 expression and mutation in human brain tumors. Acta Neurochir (Wien) 2005;147:551-4;discussion 4.
24. Sun D, Xu D, Zhang B. Rac signaling in tumorigenesis and as target for anticancer drug development. Drug Resist Updat 2006;9:274-287 (Pubitemid 46357635)
25. Lei XG, Cheng WH, McClung JP. Metabolic regulation and function of glutathione peroxidase-1. Annu Rev Nutr 2007;27:41-61.
26. Ahamed M, Siddiqui MK. Environmental lead toxicity and nutritional factors. Clin Nutr 2007;26:400-408 (Pubitemid 47091485)
27. Nishino T, Okamoto K, Eger BT, Pai EF, Nishino T. Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J 2008;275:3278-3289 (Pubitemid 351813552)
28. 2, superoxide dismutase, and xanthine oxidase. Environ Mol Mutagen 1998;31:352-361